My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metagenomi, Inc. - Common Stock
(NQ:
MGX
)
3.043
-0.287 (-8.60%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
784,043
Open
3.330
Bid (Size)
3.040 (2)
Ask (Size)
3.050 (9)
Prev. Close
3.330
Today's Range
2.970 - 3.359
52wk Range
1.230 - 4.920
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
August 12, 2025
Metagenomi Inc (NASDAQ:MGX) reported Q2 2025 earnings with revenue beating estimates at $8.51M and a narrower loss of -$0.54 per share. Shares dipped slightly amid investor caution over cash burn and...
Via
Chartmill
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
August 12, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Performance
YTD
-19.7%
-19.7%
1 Month
+66.3%
+66.3%
3 Month
+42.9%
+42.9%
6 Month
+100.2%
+100.2%
1 Year
+52.9%
+52.9%
More News
Read More
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
August 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts
December 10, 2024
Via
Benzinga
Which stocks are gapping on Wednesday?
July 09, 2025
Via
Chartmill
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
June 20, 2025
Via
Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Via
Benzinga
Demystifying Metagenomi: Insights From 4 Analyst Reviews
May 15, 2025
Via
Benzinga
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
May 15, 2025
Via
Benzinga
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
May 14, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at Upcoming Scientific Meetings
May 02, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
March 17, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
March 16, 2025
Via
Stocktwits
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
March 13, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
February 11, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Stargate, Netflix, GE Aerospace, Twilio, and More
January 29, 2025
Via
The Motley Fool
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
January 22, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Government
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 22, 2025
Via
Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
January 22, 2025
Via
Benzinga
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
January 16, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Announces New Appointment to its Board of Directors
January 15, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
December 11, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
December 09, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Metagenomi, Inc. - Common Stock publicly traded?
Yes, Metagenomi, Inc. - Common Stock is publicly traded.
What exchange does Metagenomi, Inc. - Common Stock trade on?
Metagenomi, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metagenomi, Inc. - Common Stock?
The ticker symbol for Metagenomi, Inc. - Common Stock is MGX on the Nasdaq Stock Market
What is the current price of Metagenomi, Inc. - Common Stock?
The current price of Metagenomi, Inc. - Common Stock is 3.043
When was Metagenomi, Inc. - Common Stock last traded?
The last trade of Metagenomi, Inc. - Common Stock was at 10/17/25 03:22 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.